Prof. Sir Gregory P. Winter

2018 Nobel Laureate for Chemistry at the MRC Laboratory of Molecular Biology in Cambridge/UK

Sir Gregory’s inventions provide new ways to prevent and treat immune and degenerative disorders, multiple scleroses, asthma, rheumatoid arthritis and cancer.

Biography:

Prof. Sir Gregory Paul Winter is an English molecular biologist, who is best known for his invention of techniques at the MRC Laboratory of Molecular Biology (Cambridge) for making humanized and human antibodies for therapeutic uses. This has provided new ways to prevent and treat immune and degenerative disorders, multiple scleroses, asthma, rheumatoid arthritis and cancer. One of the most successful antibody drugs developed is HUMIRA (adalimumbab) which became the world’s top selling drug, and at the current rate 3-5 new therapeutic antibodies are being approved each year. Sir Gregory filed numerous patents for his work and has founded several successful biotechnology companies to put his techniques into practice. Through these ventures he helped to translate his scientific discoveries into commercially successful products that have improved the lives of millions of people worldwide. For his work in making human antibodies by accelerated evolution he shared the Nobel Prize in Chemistry in 2018. For his contributions to molecular biology he was knighted by Queen Elizabeth and in 2012 appointed Master of Trinity College Cambridge.

Topic of keynote speech:

• The antibody revolution

Schedule:

Monday, March 2, 2026:

14:00 Public keynote speech and dialogue at Academia Sinica in Taipei

Further information and free seat reservation via phone +886-2-2789-9380 or email
emma@as.edu.tw